1. Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development. Accelerating research and development. In: Field MJ, Boat TF, editors. Rare diseases and orphan products. Washington (DC): National Academies Press (US); 2010.
2. Kaplan W, et al. Priority medicines for Europe and the world-2013 update. WHO Library; 2013. http://www.who.int/medicines/areas/priority_medicines/MasterDocJune28_FINAL_Web.pdf . Accessed 25 Aug 2015.
3. Health Grades. Statistics by country for rare diseases. Right diagnosis 2015. http://www.rightdiagnosis.com/r/rare_diseases/stats-country.htm . Accessed 21 Sept 2015.
4. Cho B-K, Tominaga T. Moyamoya disease update. 1st ed. Japan: Springer; 2010. p. 387.
5. The Economist Intelligence Unit. The shifting landscape of healthcare in Asia-Pacific. In: The Economist insights. 2015. http://www.economistinsights.com/sites/default/files/The%20shifting%20landscape%20of%20healthcare%20in%20Asia-Pacific_Oct%205.pdf . Accessed 25 Nov 2015.